Luis E Raez: Exploring the Safety and Clinical Activity of the Novel Bispecific Antibody Cesalatamig in NSCLC

Coverage, in order

1. 1d ago
   
   OncoDaily obscure study

   Luis E Raez: Exploring the Safety and Clinical Activity of the Novel Bispecific Antibody Cesalatamig in NSCLC

   Luis E Raez, Chief Scientific Officer and Medical Director of Memorial Healthcare System, shared on LinkedIn: “Memorial Cancer Institute at Memorial Healthcare System was one of the first US cancer

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.